SEC Form 4 · accession 0001645627-17-000104
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 7, 2017
Accepted (ET)
Aug 11, 2017 · 9:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2017 | P | 2,000 | $0.027 | A | 22,199,389 | D | |
| Common Stock | Aug 7, 2017 | P | 2,000 | $0.027 | A | 22,201,389 | D | |
| Common Stock | Aug 7, 2017 | P | 2,000 | $0.031 | A | 22,203,389 | D | |
| Common Stock | Aug 7, 2017 | P | 5,000 | $0.0306 | A | 22,208,389 | D | |
| Common Stock | Aug 7, 2017 | P | 2,000 | $0.029 | A | 22,210,389 | D | |
| Common Stock | Aug 8, 2017 | P | 2,000 | $0.03 | A | 22,212,389 | D | |
| Common Stock | Aug 8, 2017 | P | 2,000 | $0.03 | A | 22,214,389 | D | |
| Common Stock | Aug 8, 2017 | P | 2,000 | $0.03 | A | 22,216,389 | D | |
| Common Stock | Aug 8, 2017 | P | 2,000 | $0.0293 | A | 22,218,389 | D | |
| Common Stock | Aug 8, 2017 | P | 3,000 | $0.0299 | A | 22,221,389 | D | |
| Common Stock | Aug 8, 2017 | P | 5,000 | $0.0295 | A | 22,226,389 | D | |
| Common Stock | Aug 8, 2017 | P | 3,000 | $0.0295 | A | 22,229,389 | D | |
| Common Stock | Aug 8, 2017 | P | 2,000 | $0.0294 | A | 22,231,389 | D | |
| Common Stock | Aug 9, 2017 | P | 2,000 | $0.0305 | A | 22,233,389 | D | |
| Common Stock | Aug 9, 2017 | P | 2,000 | $0.0307 | A | 22,235,389 | D | |
| Common Stock | Aug 9, 2017 | P | 5,000 | $0.03 | A | 22,240,389 | D | |
| Common Stock | Aug 9, 2017 | P | 2,000 | $0.029 | A | 22,242,389 | D | |
| Common Stock | Aug 10, 2017 | P | 3,000 | $0.0268 | A | 22,245,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.027 | A | 22,247,389 | D | |
| Common Stock | Aug 10, 2017 | P | 5,000 | $0.027 | A | 22,252,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.027 | A | 22,254,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.027 | A | 22,256,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.027 | A | 22,258,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.027 | A | 22,260,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.027 | A | 22,262,389 | D | |
| Common Stock | Aug 10, 2017 | P | 5,000 | $0.027 | A | 22,267,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.0307 | A | 22,269,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.0299 | A | 22,271,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.0299 | A | 22,273,389 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.0286 | A | 22,275,389 | D |
Table II — derivative securities
No Table II lines on this filing.